MicroRNA-299-3p suppresses proliferation and invasion by targeting VEGFA in human colon carcinoma

• Published in: Biomedicine & pharmacotherapy Vol. 93; pp. 1047 - 1054
• Main Authors: Wang, Jia-yong, Jiang, Jin-bo, Li, Yuan, Wang, Yan-lei, Dai, Yong
• Format: Journal Article
• Language: English
• Published: France Elsevier Masson SAS 01.09.2017
• Subjects: A549 Cells; Animals; Cell Proliferation - physiology; Colon carcinoma; Colonic Neoplasms - metabolism; Colonic Neoplasms - pathology; Colonic Neoplasms - prevention & control; Humans; Invasion; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs - biosynthesis; miR-299-3p; Neoplasm Invasiveness - pathology; Neoplasm Invasiveness - prevention & control; Proliferation; Random Allocation; Vascular Endothelial Growth Factor A - antagonists & inhibitors; Vascular Endothelial Growth Factor A - biosynthesis; VEGFA; Xenograft Model Antitumor Assays - methods; miR-299-3p; Proliferation; Colon carcinoma; Invasion; VEGFA
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2017.07.030

•miR-299-3p expression was down-regulated in colon cancer.•miR-299-3p level was negatively correlated with VEGFA level.•miR-299-3p could target VEGFA 3′ UTR.•miR-299-3p functioned as a suppressor by targeting VEGFA. Accumulating evidences have shown that microRNAs (miRNAs) are vital regulators and possess huge capabilities in post-transcriptional control. Although a large number of miRNAs have been identified to be dysregulated in human cancers especially in colon cancer, our understandings of the function of most miRNAs are still largely limited. In this study, we have demonstrated that miR-299-3p plays a critical role in suppressing colon carcinoma progression by targeting Vascular Endothelial Growth Factor A (VEGFA). We observed that miR-299-3p was down-regulated in colon carcinoma tissues and colon cancer cell lines. The level of miR-299-3p was significantly negatively correlated with that of VEGFA mRNA level in colon carcinoma. More importantly, the low level of miR-299-3p predicted poor prognosis of colon cancer patients. Functionally, overexpression of miR-299-3p inhibited the proliferation and invasion of colon carcinoma cells and suppressed the growth of colon cancer xenografts in nude mice. Luciferase reporter assays showed that miR-299-3p could target VEGFA 3′ UTR. In addition, up-regulation of miR-299-3p decreased VEGFA expression both in vitro and in vivo, showing that miR-299-3p plays a suppressive effect on VEGFA via post-transcriptional control. However, ectopical expression of VEGFA could abrogate this effect and also abolish miR-299-3p-induced inhibition of cell proliferation and invasion. Taken together, our study provides evidences showing that miR-299-3p functions as a suppressor in colon cancer by targeting VEGFA, suggesting that miR-299-3p might serve as a novel target for colon cancer therapy.